Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.58
-0.05 (-1.38%)
At close: Aug 21, 2025, 11:18 AM

Altimmune Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-22.15M -19.57M -23.18M -22.84M -24.64M -24.39M -31.64M -20.67M -16.06M -20.07M -21.66M -23.52M -20.11M -19.43M -23.89M -33.51M -24.83M -14.86M
Depreciation & Amortization
30K 29K 33K 37K 61K 107K 1.89M -552K -505K -356K -236K -141K 53K 119K 117.29K 284.62K 75.09K 74.3K
Stock-Based Compensation
3.57M 4.01M 3.35M 3.08M 4.31M 3.65M 2.47M 2.71M 2.79M 2.67M 1.89M 2.13M 2.05M 2.03M 1.32M 1.5M 1.48M 1.22M
Other Working Capital
-1.83M -2.13M 3.16M -5.7M 4.66M 1.29M 2.12M -242K -3.94M -354K -1.36M 8.42M -1.18M 5.24M -5.79M 10.27M -3.81M -6.53M
Other Non-Cash Items
-328K -701K -936K 1.02M -996K -975K 9.93M -2K -114K -18K 217K -49K 1.87M -1.78M 3.11M 1.97M 7.05M 913.38K
Deferred Income Tax
n/a -681K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -110K 3.97M 287.03K 8.05M 33.38K
Change in Working Capital
-472K 73K 2.46M -8.41M 3.16M 5.25M 821K -1.97M -5.49M -1.63M 2.48M 6.53M -540K 5.64M -2.62M 11.99M -2.71M -6.91M
Operating Cash Flow
-19.35M -16.84M -18.27M -27.12M -18.11M -16.36M -16.53M -20.49M -19.38M -19.41M -17.31M -15.05M -16.7M -13.53M -21.97M -17.78M -18.93M -19.57M
Capital Expenditures
-10K n/a n/a n/a n/a n/a n/a n/a 4K -51K -38K -60K -19K -9K -151.82K -114.08K -7.77M -4.27M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a -3.98M -13.35M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-4.43M -43.14M -13.21M -25.8M -23.2M -53.52M -33.83M -11.58M -22.02M -21.21M 1.02M -25.34M -48.95M n/a -138 -167.96K 52.07K -7.48M
Sales Maturities Of Investments
105.55M 38.04M 26.84M 27M 19.5M 14M 25.87M 15.98M 26M 34.56M n/a n/a n/a n/a 25.02M 18.69M 32.8M 30.91M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a 13.35M 1.02M -25.34M -48.95M n/a -4.89K -44.1K -83.5K -62.04K
Investing Cash Flow
101.11M -5.1M 13.63M 1.2M -3.7M -39.52M -7.96M 4.4M 3.99M 13.3M 981K -25.4M -48.97M -9K 24.87M 18.41M 25.08M 19.17M
Debt Repayment
14.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a 170K n/a n/a n/a n/a n/a n/a n/a n/a -125K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-304K -799K 10.38M 135K -244K -430K -37K -2K -287K -437K n/a 163K -2.75M 3.07M 12.54M 6K -159K 135K
Financial Cash Flow
52.24M 34.12M 10.09M 266K -46K -261K 72.75M 588K 13.06M -289K -43K 32.06M 21.58M 3.18M 12.54M 125K 18.02M 34.42M
Net Cash Flow
134M 12.18M 5.45M -25.65M -21.85M -56.14M 48.26M -15.5M -2.33M -6.41M -16.37M -8.39M -44.09M -10.35M 15.44M 761.18K 24.17M 34.01M
Free Cash Flow
-19.36M -16.84M -18.27M -27.12M -18.11M -16.36M -16.53M -20.49M -19.38M -19.46M -17.34M -15.11M -16.72M -13.54M -22.12M -17.89M -26.7M -23.84M